6 Programs
Sort by
6 Programs
Find Your Dream Program
Research & Development Technician
Job role insights
-
Date posted
August 9, 2024
-
Deadline
August 9, 2024
-
Study location
Hong Kong
-
Tuitions
Competitive
-
Qualification
Doctorate Degree
Description
Job no: H03/2023/06
Location: Hong Kong Science Park
Role type: Full time
Centre for Oncology and Immunology Limited
The long-term objective of the Centre for Oncology and Immunology is to employ novel functional screens, animal and cell models including organoids, immuno-oncology approach, as well as advanced genomic and proteomic techniques down to single cell resolution to identify novel “druggable” cancer targets for hard-to-treat malignancies. The ultimate goal is to develop therapeutics against these targets and to conduct clinical trials evaluating these drugs along with biomarkers with an eye to their eventual commercialization worldwide. Success in this venture will address pressing unmet medical needs and establish Hong Kong as a leading hub of innovative anti-cancer and immuno-oncology drug development.
Job responsibilities:
Applications are invited for appointment as Research & Development Technician (Ref.: H03/2023/06), to commence as soon as possible, on a fixed-term basis, with the possibility of renewal subject to satisfactory performance and mutual agreement.
The appointees are expected to assist collaborative research projects in discovery of cancer biomarkers using large scale multi-omics approach, organoid technology and novel animal models, as well as anti-cancer or immuno-oncology drug development.
Qualifications and skills:
Applicants should possess a Bachelor degree or above, preferably in Biomedical Sciences or related disciplines, with at least 1 year of experience in providing technical support to end-users and maintenance of lab equipment. He/She would also need to assist in the daily operation of a biomedical research laboratory. Relevant work experiences at the local universities and research core facilities will be an asset.
Familiar with relevant research techniques in FACS analysis, Molecular Biology, CRISPR technologies, Single Cell Technologies, Next Generation Sequencing, 2D/3D Tissue Culture, PCR, Western Blot, ELISA, Cloning, or Drug screening would be an advantage.
The applicants should have a good command of written and spoken English and strong communication skills, team player, self-motivated, organized, detail- minded, hardworking, willing to learn new techniques, and able to work well in a multidisciplinary team.
The appointee shall work in Hong Kong Science and Technology Park.
Overseas graduates are welcome to apply, the qualification awarding institution should be the top 100 institutions for STEM-related subjects in QS/Shanghai Jiao Tong Uni/Times Higher Education/U.S. News world university rankings.
A highly competitive salary commensurate with qualifications and experience will be offered, in addition to annual leave and medical benefits.
How to apply:
Applicants should submit their up-to-date C.V. and research publication list (where applicable), quoting the job reference number, with information of current/expected remuneration and availability, to career@coinno.hk or by clicking "Apply".
Review of applications will commence as soon as possible and continue until the posts are filled.
The personal data provided in your application process will be used for recruitment and other employment-related purposes. The personal data may be transferred and disclosed to, and used by HKU Innovation Holdings Limited and The University of Hong Kong for the above purposes.
We are an equal opportunities employer and welcome applications from all qualified candidates.
Overview
Digestive malignancies, including gastric, colorectal, liver and esophageal cancers as well as leukemias and lymphomas, are major health burdens in Asian countries. Today, gastrointestinal and liver cancers are becoming more common across Asia due to population aging, growth, and a rise in risk factors ranging from oncogenic pathogen infections to increased smoking and obesity.
Under the auspices of the InnoHK initiative, the Centre for Oncology and Immunology aims to harness the power of biotechnology to develop innovative therapies to combat these hard-to-treat malignancies and bring hope to millions of cancer patients around the world.
The Centre's research team comprises globally renowned researchers who bring with them a wealth of complementary expertise and experience in oncology research, technology adoption, and commercialisation. Individually, their research programs have led to major breakthroughs, including the devising of immunotherapy and checkpoint inhibition strategies that have been adopted as anti-cancer treatments, the establishment of next-generation organoid-based cell models for precision oncology, and the development of a diagnostic test for Lynch Syndrome (hereditary colon cancer).
The Centre will employ novel functional screens as well as genomic and proteomic techniques to identify novel "druggable" cancer targets. Leveraging the translational and clinical trial expertise of its lead scientists, the Centre will establish a number of advanced technical platforms to facilitate its overall goal of bringing candidate drugs and novel immunotherapy approaches into clinics.
As an international business hub at the heart of Asia, Hong Kong encourages collaborations between renowned research institutes and global pharmaceutical companies. Building on the city's robust healthcare system and diligent compliance with the research ethics requirements for the use of clinical samples, it will facilitate the Centre's aspiration to make Hong Kong a leading nexus of innovative anti-cancer drug discovery and production.
Read moreSchool size
100-500
Founded in
1800
Location
Hong Kong
Phone
Interested in this job?
383 days left to apply
